The specificity of serum CPK-MB for acute myocardial infarction was examined by retrospective analysis of 401 consecutive patients admitted to a Coronary Care Unit over a three and one-half year period with suspected infarction in whom the isoenzyme was subsequently detected. Four patients (1% ) who died during the hospital admission had no autopsy evidence of acute myocardial infarction. All four had experienced mild iatrogenic cardiac trauma, following which serum CPK-MB persisted for at least 24 hours. In one patient, a permanent pacemaker had been inserted by the transmediastinal approach. Two patients had been subjected to closed chest cardiac massage and intracardiac puncture, and one to external cardiac massage alone. The findings suggest that persistent identification of serum CPK-MB, although specific for myocardial necrosis, cannot be regarded as diagnostic of myocardial infarction. The implications of this are important to treatment of patients after cardiopulmonary resuscitation and operative trauma to the heart.
AMI but with myocardial necrosis secondary to cardiac trauma. The implication of these findings for the diagnosis of AMI after cardiopulmonary resuscitation and cardiac surgery constitutes the reason for this report.
Methods

Patients
Those patients admitted to the Coronary Care Unit of Duke University Medical Center between January 1, 1971, and June 30, 1974, with suspected AMI constitute the study population. The patients were managed routinely. Twelvelead electrocardiograms were taken daily and venous blood samples for analysis of serum enzymes and isoenzymes drawn twice daily (at 6:00 A.M. and 6:00 P.M.).
Biochemical Procedures
Blood samples were withdrawn by the vacutainer technique, into a tube containing EDTA as anticoagulant. Plasma was immediately separated from the cells by centrifugation, and the plasma samples frozen until enzyme and isoenzyme determinations were made within 24 hours.
Plasma CPK was determined by the method of Rosalki,"l using the modified reagent substrate prepared by Eskalab (normal value for the laboratory 0-130 I.U.). Determinations were carried out on the Eskalab Clinical Chemistry System (Smith-Kline Instruments Inc., Palo Alto, California).
Isoenzymes of CPK and LDH were determined electrophoretically on a supporting medium of 1% ionagar, using methods described by Nerenberg and Pogojeff" for LDH, TONKIN ET AL.
and Roe et al. 13 for CPK. The LDH isoenzymes were visualized by precipitation of formazan, while CPK isoenzymes were quantitated fluorimetrically. using the Clifford 445 Densicomp (Clifford Instruments Inc., Natick, Mass.). Mlyocardial infarction is characterized by appearance of serum CPK-MB (normal 0 I.U.) and elevation of LDH isoenzyme 1 to a level greater than LDH isoenzvme 2.
Pathological Methods
For gross examination, formalin-fixed hearts were sectioned by four equally spaced cross cuts through the ventricles and the interventricular septum between the apex and base. At each level, blocks were taken from the anterior, lateral and posterior regions of the left ventricle, anteriorly and posteriorly in the interventricular septum, and in the region of the right ventricle. For microscopic examination, these blocks were fixed in Zenker's solution, embedded, and stained with hematoxylin and eosin and with Masson's stain.
Results
Over the 31/2 year period, serum CPK-MB was identified in 401 patients admitted to the Coronary Care Unit with a diagnosis of suspected AMI. Of these, 274 patients (68%) had electrocardiographic evidence of AMI, developing new Q waves, or in the absence of prior tracings, evolutionary ST-segment and T-wave changes indicative of epicardial injury associated with prior QRS indication of infarction.
Of the 127 patients (32Cc) who had serum CPK-MB but did not show electrocardiographic changes diagnostic of AMI, 18 died. Autopsy was performed in 11 of these 18, and postmortem evidence of AMI found in six.
Five patients had no autopsy evidence of AMI. One died approximately eight hours after the onset of acute dyspnea and chest pain. He remained hypotensive and in frank pulmonary edema until his death. Although at autopsy only old myocardial infarction was found, it is most likely that AMI was not identified because death preceded the development of morphological changes. Serum CPK-MB, therefore, could not be considered to be falsely-positive in this patient.
A history of iatrogenic cardiac trauma was present in the other four patients without AMI at autopsy. The relevant clinical data and autopsy findings on these four patients is presented in table 1. Their enzyme and isoenzyme levels over the three days after trauma are shown in table 2. After occurrence of cardiac trauma, all four had serum CPK-MB identified for at least 24 hours, and they survived a sufficient period for AMI to be recognized at autopsy. In none of the four did there appear to have been extensive myocardial damage. No greater than the usual inflammatory reaction was identified about the pacemaker electrodes in patient 1, and the needle tracks in patients 2 and 3 had not traumatized major coronary vessels. Needle tracks were thought to be responsible for two 
Discussion
The three isoenzymes of CPK differ in their dimer structure.6' 14 The BB and MM isoenzymes are located primarily in brain and skeletal muscle, respectively, although significant concentrations of the MM form are present in the heart. The hybrid MB isoenzyme is detected almost exclusively in the myocardium, and the small proportion of CPK-MB in skeletal muscle has been reported to vary between 0-20% of its concentration in the heart.6 15. 16 Normally, CPK-MB cannot be detected in the serum. It may be released from skeletal muscle in such disorders as progressive muscular dystrophy, dermatomyositis, or conditions associated with myoglobinuria,'2 but these conditions can be clinically recognized. Its importance for the diagnosis of AMI rests chiefly upon its specificity for myocardial damage. Wagner et al.8 found only a 1%c incidence of false positivity for serum CPK-MB in the diagnosis of AMI in a Coronary Care Unit. They showed that the isoenzyme is present in the serum for periods of between 24-72 hours after an initial appearance at 2-12 hours after the onset of symptoms of AMI.
The myocardial-specificity of CPK-MB is even more valuable after cardiac surgery when other criteria for AMI have many limitations. In this period, 1) cardiac pain may be either indistinguishable from that of the operative wound or masked by analgesics and the true significance of fever, tachycardia or hypotension also not appreciated, 2) most patients develop ST-segment and T-wave changes, often due to other causes such as pericarditis or myocardial ischemia without infarction,`0 and 3) total serum CPK rises for approximately 72 hours because of the skeletal muscle trauma with operation.3' 17 Identification of serum CPK-MB for the accurate diagnosis of AMI complicating myocardial revascularization in potentially susceptible patients is especially important. In a previous study of 100 consecutive patients undergoing coronary artery bypass grafting at this institution, 22 This present study showed that six of the eleven autopsy patients with serum CPK-MB but no electrocardiographic evidence of AMI had, in fact, sustained infarction. This confirms the previous findings8 suggesting the relative insensitivity of the electrocardiogram as compared with serum CPK-MB in the diagnosis of AMI. However, this updated analysis has provided more information concerning the specificity of serum CPK-MB. The incidence of falsepositivity for AMI has again been shown to be 1%. However, the true incidence may well be higher as pathological data was available on only 11 
